Claudie Morzadec

1.5k total citations
34 papers, 1.1k citations indexed

About

Claudie Morzadec is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claudie Morzadec has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claudie Morzadec's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Retinoids in leukemia and cellular processes (9 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Claudie Morzadec is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Retinoids in leukemia and cellular processes (9 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Claudie Morzadec collaborates with scholars based in France, Germany and South Korea. Claudie Morzadec's co-authors include Laurent Vernhet, Olivier Fardel, Anthony Lemarié, Emilie Bourdonnay, S. Jouneau, Valérie Lecureur, Dominique Lagadic‐Gossmann, Nathalie Allain, Lydie Sparfel and Alice Ballerie and has published in prestigious journals such as The Journal of Immunology, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Claudie Morzadec

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudie Morzadec France 20 418 355 306 268 195 34 1.1k
Hsin‐Su Yu Taiwan 14 340 0.8× 174 0.5× 142 0.5× 163 0.6× 40 0.2× 26 907
Qingling Wang China 18 530 1.3× 113 0.3× 100 0.3× 162 0.6× 70 0.4× 54 915
Lan Gao China 19 277 0.7× 56 0.2× 337 1.1× 69 0.3× 120 0.6× 49 912
Takamasa Ohnishi Japan 18 276 0.7× 84 0.2× 126 0.4× 120 0.4× 51 0.3× 48 862
Haiyan Wei China 21 467 1.1× 76 0.2× 153 0.5× 116 0.4× 89 0.5× 45 1.0k
Melinda D. Treadwell United States 11 258 0.6× 134 0.4× 174 0.6× 136 0.5× 163 0.8× 13 698
Karen L. Pennington United States 19 430 1.0× 48 0.1× 221 0.7× 209 0.8× 36 0.2× 59 1.1k
Jiawen Cui China 17 192 0.5× 160 0.5× 187 0.6× 20 0.1× 56 0.3× 37 780
Lili Zhuang China 17 393 0.9× 229 0.6× 61 0.2× 42 0.2× 65 0.3× 65 901

Countries citing papers authored by Claudie Morzadec

Since Specialization
Citations

This map shows the geographic impact of Claudie Morzadec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudie Morzadec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudie Morzadec more than expected).

Fields of papers citing papers by Claudie Morzadec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudie Morzadec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudie Morzadec. The network helps show where Claudie Morzadec may publish in the future.

Co-authorship network of co-authors of Claudie Morzadec

This figure shows the co-authorship network connecting the top 25 collaborators of Claudie Morzadec. A scholar is included among the top collaborators of Claudie Morzadec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudie Morzadec. Claudie Morzadec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lelong, M, Claudie Morzadec, Alice Ballerie, et al.. (2024). Efferocytosis dysfunction in CXCL4-induced M4 macrophages: phenotypic insights in systemic sclerosis in vitro and in vivo. Frontiers in Immunology. 15. 1468821–1468821. 5 indexed citations
2.
Joannes, Audrey, et al.. (2024). Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. The Journal of Nutritional Biochemistry. 125. 109558–109558. 3 indexed citations
3.
Joannes, Audrey, Claudie Morzadec, Stéphanie Guillot, et al.. (2023). Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). Pulmonary Pharmacology & Therapeutics. 83. 102267–102267. 6 indexed citations
4.
Joannes, Audrey, Claudie Morzadec, B. de Latour, et al.. (2022). Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Toxicology and Applied Pharmacology. 441. 115972–115972. 8 indexed citations
5.
Chauvin, Pierre, Claudie Morzadec, B. de Latour, et al.. (2022). Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis. Innate Immunity. 28(3-4). 138–151. 5 indexed citations
6.
Lescoat, Alain, M Lelong, Mohamed Jeljeli, et al.. (2020). Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease. Biochemical Pharmacology. 178. 114103–114103. 107 indexed citations
7.
Lescoat, Alain, Alice Ballerie, M Lelong, et al.. (2020). Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis. Frontiers in Immunology. 11. 219–219. 57 indexed citations
8.
Ballerie, Alice, M Lelong, Claudie Morzadec, et al.. (2019). THU0003 CRYSTALLINE SILICA IMPAIRS EFFEROCYTOSIS CAPACITIES OF HUMAN MONOCYTE-DERIVED MACROPHAGES THROUGH RHOA-ROCK ACTIVATION. Annals of the Rheumatic Diseases. 78. 267–268. 1 indexed citations
9.
Morzadec, Claudie, Audrey Joannes, Valérie Lecureur, et al.. (2019). Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib. International Immunopharmacology. 72. 112–123. 46 indexed citations
10.
Joannes, Audrey, et al.. (2019). Arsenic trioxyde inhibits the functions on lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. HAL (Le Centre pour la Communication Scientifique Directe). PA5373–PA5373. 1 indexed citations
11.
Rousseau, Chloé, et al.. (2018). TNF-a and IL-10 control macrophage expression of CXCL13, a prognostic biomarker of idiopathic pulmonary fibrosis. HAL (Le Centre pour la Communication Scientifique Directe). PA4812–PA4812.
12.
Morzadec, Claudie, et al.. (2014). Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone. Free Radical Biology and Medicine. 71. 133–145. 58 indexed citations
13.
Morzadec, Claudie, et al.. (2012). Inorganic arsenic impairs differentiation and functions of human dendritic cells. Toxicology and Applied Pharmacology. 266(2). 204–213. 22 indexed citations
14.
Martin‐Chouly, Corinne, Claudie Morzadec, Mélodie Bonvalet, et al.. (2011). Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Molecular Immunology. 48(6-7). 956–965. 41 indexed citations
15.
Bourdonnay, Emilie, Claudie Morzadec, Olivier Fardel, & Laurent Vernhet. (2011). Arsenic increases lipopolysaccharide-dependent expression of interleukin-8 gene by stimulating a redox-sensitive pathway that strengthens p38-kinase activation. Molecular Immunology. 48(15-16). 2069–2078. 12 indexed citations
16.
Bourdonnay, Emilie, Claudie Morzadec, Lydie Sparfel, et al.. (2009). Global effects of inorganic arsenic on gene expression profile in human macrophages. Molecular Immunology. 46(4). 649–656. 39 indexed citations
17.
Lemarié, Anthony, Emilie Bourdonnay, Claudie Morzadec, Olivier Fardel, & Laurent Vernhet. (2008). Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway. The Journal of Immunology. 180(9). 6010–6017. 54 indexed citations
18.
Vernhet, Laurent, Claudie Morzadec, Julien van Grevenynghe, et al.. (2008). Inorganic arsenic induces necrosis of human CD34‐positive haematopoietic stem cells. Environmental Toxicology. 23(2). 263–268. 10 indexed citations
19.
Lemarié, Anthony, Claudie Morzadec, Emilie Bourdonnay, Olivier Fardel, & Laurent Vernhet. (2006). Human Macrophages Constitute Targets for Immunotoxic Inorganic Arsenic. The Journal of Immunology. 177(5). 3019–3027. 110 indexed citations
20.
Lemarié, Anthony, Claudie Morzadec, Delphine Mérino, et al.. (2005). Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down-Regulation. Journal of Pharmacology and Experimental Therapeutics. 316(1). 304–314. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026